Patents by Inventor Nico Tjandra

Nico Tjandra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF INHIBITING VIRUSES USING COMPOSITIONS TARGETING TSG101-UBIQUITIN INTERACTION
    Publication number: 20200038388
    Abstract: The present invention provides a method of inhibiting release of a virus from a cell, comprising contacting the cell with a compound that binds an ubiquitin E2 variant (UEV) domain of a cellular polypeptide, or fragment thereof, with an affinity sufficient to inhibit or disrupt the binding of the cellular polypeptide, or fragment thereof, to ubiquitin.
    Type: Application
    Filed: October 30, 2017
    Publication date: February 6, 2020
    Applicants: The Research Foundation for the State University of New York, THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Carol Carter, Lorna Erlich, Nico Tjandra, Madeleine Davison
  • Methods and compositions for modulating BCL-2 family polypeptides
    Patent number: 8921323
    Abstract: The present invention is based, at least in part, on the identification of a novel active site on BCL-2 family polypeptide such as BAX, which when bound by a compound, modifies the activity of the BCL-2 family polypeptide.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: December 30, 2014
    Assignees: Dana Farber Cancer Institute, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Loren D. Walensky, Nico Tjandra, Evripidis Gavathiotis, Motoshi Suzuki, Gregory Bird
  • METHODS AND COMPOSITIONS FOR MODULATING BCL-2 FAMILY POLYPEPTIDES
    Publication number: 20100286057
    Abstract: The present invention is based, at least in part, on the identification of a novel active site on BCL-2 family polypeptide such as BAX, which when bound by a compound, modifies the activity of the BCL-2 family polypeptide.
    Type: Application
    Filed: September 26, 2008
    Publication date: November 11, 2010
    Applicants: DANA FARBER CANCER INSTITUTE, NATIONAL INSTITUTES OF HEALTH
    Inventors: Loren D. Walensky, Nico Tjandra, Evripidis Gavathiotis, Motoshi Suzuki, Gregory H. Bird